A new role for interleukin-10 in immune regulation

Immunology and Cell Biology

Volumn 88, Issue 8, 2010, Pages 769-770

  Pierson, Wim ^a   Liston, Adrian ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; PROINSULIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSFER; CYTOLYSIS; DIABETES MELLITUS; DISEASE COURSE; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MUCOSAL IMMUNITY; NONHUMAN; NOTE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TRANSGENE;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FEEDBACK, PHYSIOLOGICAL; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; INTERLEUKIN-10; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 78649330397     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.105     Document Type: Note

References (14)

1. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181.
2. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell1993; 75: 263-274.
3. Hillhouse EE, Beauchamp C, Chabot-Roy G, Dugas V, Lesage S. Interleukin-10 limits the expansion of immunoregulatory CD4(\)CD8(\) T cells in autoimmune-prone non-obese diabetic mice. Immunol Cell Biol 2010; 88: 771-780.
4. Narendran P, Mannering SI, Harrison LC. Proinsulin-a pathogenic autoantigen in type 1 diabetes. Autoimmun Rev2003; 2: 204-210.
5. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361: 2143-2152.
6. Dugas V, Beauchamp C, Chabot-Roy G, Hillhouse EE, Lesage S. Implication of the CD47 pathway in autoimmune diabetes. J Autoimmun 2010; 35: 23-32.
7. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28: 546-558.
8. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H et al. Interleukin 10 acts on regulatory T cel ls to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009; 10: 1178-1184.
9. Go NF, Castle BE, Barrett R, Kastelein R, Dang W, Mosmann TR et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990; 172: 1625-1631.
10. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890-1893.
11. Pauza ME, Neal H, Hagenbaugh A, Cheroutre H, Lo D. T-cell production of an inducible interleukin-10 trans-gene provides limited protection from autoimmune diabetes. Diabetes 1999; 48: 1948-1953.
12. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immuno-pathol 1994; 71: 169-175.
13. Lee MS, Mueller R, Wicker LS, Peterson LB, Sarvetnick N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 1996; 183: 2663-2668.
14. Chen Z, Herman AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 2005; 202: 1387-1397.